These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 22779429)
21. Activity of di-beta-lysyl-capreomycin IIA and palmitoyl tuberactinamine N against drug-resistant mutants with altered ribosomes. Yamada T; Teshima T; Shiba T Antimicrob Agents Chemother; 1981 Dec; 20(6):834-6. PubMed ID: 6173016 [TBL] [Abstract][Full Text] [Related]
22. The structural basis for inhibition of ribosomal translocation by viomycin. Zhang L; Wang YH; Zhang X; Lancaster L; Zhou J; Noller HF Proc Natl Acad Sci U S A; 2020 May; 117(19):10271-10277. PubMed ID: 32341159 [TBL] [Abstract][Full Text] [Related]
23. Resistance to the antibiotics viomycin and capreomycin in the Streptomyces species which produce them. Skinner RH; Cundliffe E J Gen Microbiol; 1980 Sep; 120(1):95-104. PubMed ID: 6163840 [TBL] [Abstract][Full Text] [Related]
24. Structural and functional characterization of Rv2966c protein reveals an RsmD-like methyltransferase from Mycobacterium tuberculosis and the role of its N-terminal domain in target recognition. Kumar A; Saigal K; Malhotra K; Sinha KM; Taneja B J Biol Chem; 2011 Jun; 286(22):19652-61. PubMed ID: 21474448 [TBL] [Abstract][Full Text] [Related]
25. In vitro microbiological characterization of novel cyclic homopentapeptides, CP-101,680 and CP-163,234, for animal health use. Norcia LJ; Silvia AM; Dirlam JP; Schnur RC; Bergeron JM; Retsema JA; Hayashi SF J Antibiot (Tokyo); 1999 Nov; 52(11):1007-16. PubMed ID: 10656573 [TBL] [Abstract][Full Text] [Related]
26. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983 [TBL] [Abstract][Full Text] [Related]
27. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. Tsukamura M; Mizuno S J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402 [TBL] [Abstract][Full Text] [Related]
28. The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome. Stanley RE; Blaha G; Grodzicki RL; Strickler MD; Steitz TA Nat Struct Mol Biol; 2010 Mar; 17(3):289-93. PubMed ID: 20154709 [TBL] [Abstract][Full Text] [Related]
29. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis]. Tomoda T; Minami Y; Maekawa Y; Oi Y Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341 [No Abstract] [Full Text] [Related]
30. Characterization of a novel mutation in the overlap of tlyA and ppnK involved in capreomycin resistance in Mycobacterium. Du Q; Long Q; Mao J; Fu T; Duan X; Xie J IUBMB Life; 2014 Jun; 66(6):405-14. PubMed ID: 24890219 [TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system. Taniguchi H; Chang B; Abe C; Nikaido Y; Mizuguchi Y; Yoshida SI J Bacteriol; 1997 Aug; 179(15):4795-801. PubMed ID: 9244267 [TBL] [Abstract][Full Text] [Related]
32. YccW is the m5C methyltransferase specific for 23S rRNA nucleotide 1962. Purta E; O'Connor M; Bujnicki JM; Douthwaite S J Mol Biol; 2008 Nov; 383(3):641-51. PubMed ID: 18786544 [TBL] [Abstract][Full Text] [Related]
33. Binding energies of the drugs capreomycin and streptomycin in complex with tuberculosis bacterial ribosome subunits. Vianna JF; S Bezerra K; I N Oliveira J; Albuquerque EL; Fulco UL Phys Chem Chem Phys; 2019 Sep; 21(35):19192-19200. PubMed ID: 31436279 [TBL] [Abstract][Full Text] [Related]
34. YebU is a m5C methyltransferase specific for 16 S rRNA nucleotide 1407. Andersen NM; Douthwaite S J Mol Biol; 2006 Jun; 359(3):777-86. PubMed ID: 16678201 [TBL] [Abstract][Full Text] [Related]
35. Some experimental aspects of cross-resistance between capreomycin and viomycin. Algeorge G; Petre A Antibiot Chemother; 1970; 16():32-5. PubMed ID: 4108892 [No Abstract] [Full Text] [Related]
36. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)]. Saito T; Fukuhara Y Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393 [No Abstract] [Full Text] [Related]
37. Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin. Felnagle EA; Rondon MR; Berti AD; Crosby HA; Thomas MG Appl Environ Microbiol; 2007 Jul; 73(13):4162-70. PubMed ID: 17496129 [TBL] [Abstract][Full Text] [Related]
38. Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis. Sirgel FA; Tait M; Warren RM; Streicher EM; Böttger EC; van Helden PD; Gey van Pittius NC; Coetzee G; Hoosain EY; Chabula-Nxiweni M; Hayes C; Victor TC; Trollip A Microb Drug Resist; 2012 Apr; 18(2):193-7. PubMed ID: 21732736 [TBL] [Abstract][Full Text] [Related]
39. CAPREOMYCIN SUSCEPTIBILITY OF STRAINS RESISTANT TO STREPTOMYCIN AND/OR VIOMYCIN. VERBIST L; GYSELEN A Am Rev Respir Dis; 1964 Oct; 90():640-1. PubMed ID: 14221679 [No Abstract] [Full Text] [Related]
40. The ototoxic interaction of viomycin, capreomycin and polymyxin B with ethacrynic acid. Davis RR; Brummett RE; Bendrick TW; Himes DL Acta Otolaryngol; 1982; 93(1-6):211-7. PubMed ID: 6175163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]